Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Weekly Taxol® Plus Xeloda® Versus Taxotere® Every Three Weeks Plus Xeloda® in the Treatment of Metastatic Breast Cancer A Phase II/III Study

NCT00201435 is registered in ClinicalTrials.gov with Norwegian Breast Cancer Group as lead sponsor.

NCT NCT00201435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00201435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Weekly Taxol® Plus Xeloda® Versus Taxotere® Every Three Weeks Plus Xeloda® in the Treatment of Metastatic Breast Cancer A Phase II/III Study
Lead sponsor
Norwegian Breast Cancer Group
Phase
Phase 2/3
Overall status
Completed
Start date
March 31, 2005
Completion date
May 31, 2008
Enrollment
224 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm